ALPS ETF TR - MED BREAKTHGH (SBIO)

Q3 2017 13F Holders as of 30 Sep 2017

Type / Class
Equity / MED BREAKTHGH
Number of holders
28
Total 13F shares, excl. options
617,099
Shares change
+20,503
Total reported value, excl. options
$19,236,387
Value change
+$714,608
Put/Call ratio
75.4%
Number of buys
15
Number of sells
-9
Price
$31.17

Significant Holders of ALPS ETF TR - MED BREAKTHGH (SBIO) as of Q3 2017

34 filings reported holding SBIO - ALPS ETF TR - MED BREAKTHGH as of Q3 2017.
ALPS ETF TR - MED BREAKTHGH (SBIO) has 28 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 617,099 shares .
Largest 10 shareholders include UBS Group AG (162,422 shares), BANK OF AMERICA CORP /DE/ (132,673 shares), BAROMETER CAPITAL MANAGEMENT INC. (84,100 shares), MORGAN STANLEY (48,972 shares), RAYMOND JAMES & ASSOCIATES (47,449 shares), ROYAL BANK OF CANADA (24,478 shares), CAMBRIDGE TRUST CO (20,908 shares), Virtu Financial LLC (19,861 shares), NTV ASSET MANAGEMENT LLC (16,800 shares), and LPL Financial LLC (14,766 shares).
This table shows the top 28 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.